StockStory.org on MSN16h
Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services StocksEarnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...
Explore Pacific Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PACB. Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific ...
3d
Zacks Investment Research on MSNPacific Biosciences of California (PACB) Increases Yet Falls Behind Market: What Investors Need to KnowPacific Biosciences of California (PACB) ended the recent trading session at $1.22, demonstrating a +1.67% swing from the preceding day's closing price. The stock's change was less than the S&P 500's ...
Pacific Biosciences of California (PACB) closed the latest trading day ... estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank ...
Bernstein analyst Eve Burstein maintained a Buy rating on Pacific Biosciences (PACB – Research Report) today and set a price target of $2.00.
New York State Common Retirement Fund raised its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – ...
Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener ... Read More on PACB: Pacific Biosciences of California NewsMORE Related Stocks Indices ...
3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever PACB stock opened at $1.56 on Tuesday. Pacific Biosciences of California has a 12-month low of $1.16 ...
Pacific Biosciences' Q4'24 results were another disappointment ... Growth in clinical and diagnostic markets will help, but not right away, and PACB is likely to remain below $100M in annualized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results